Target Name: LOC105376234
NCBI ID: G105376234
Review Report on LOC105376234 Target / Biomarker Content of Review Report on LOC105376234 Target / Biomarker
LOC105376234
Other Name(s): Uncharacterized LOC105376234, transcript variant X2 | uncharacterized LOC105376234 | LOC105376234 variant X2

LOC105376234: A Potential Drug Target and Biomarker

Abstract:

LOC105376234 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and expression patterns have drawn the attention of researchers, who are investigating its potential role in various diseases. In this article, we will provide an overview of LOC105376234, its potential drug target status, and its potential as a biomarker.

Introduction:

LOC105376234 is a non-coding RNA molecule that has been identified by bioinformatic analysis as having potential utility as a drug target and biomarker. Its unique structure, such as a potential intron-exon splice signature and a conserved region, has led to its investigation as a potential drug target. Additionally, its expression patterns have been observed in various biological processes, including cell growth, apoptosis, and inflammation, which has suggested its potential as a biomarker.

Location and Expression:

LOC105376234 is a non-coding RNA molecule that is located within the gene X2. It has a length of 294 nucleotides and an estimated 11-mer exon. The molecule has been identified by bioinformatic analysis as having a potential intron-exon splice signature, with the exon starting at nucleotide position +6 and the intron starting at nucleotide position -3. Additionally, a conserved region is located between nucleotide positions +15 and +50, which consists of 21 nucleotides.

Structure and Potential Drug Target:

The unique structure of LOC105376234, including the potential intron-exon splice signature and conserved region, has suggested that it may have potential as a drug target. Intron-exon splice signatures are known to play a crucial role in the regulation of gene expression, and the conserved region may be involved in the regulation of LOC105376234 expression.

Additionally, the molecule has been shown to have potential drug target interactions with various signaling pathways, including the PI3K/Akt signaling pathway. This suggests that LOC105376234 may be a drug target that can be modulated by small molecules, which could have potential therapeutic benefits.

Biomarker Potential:

LOC105376234 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Its expression patterns have been observed in various biological processes, including cell growth, apoptosis, and inflammation. This suggests that LOC105376234 may be a useful biomarker for monitoring disease progression and evaluating the effectiveness of therapeutic interventions.

Conclusion:

LOC105376234 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and expression patterns have drawn the attention of researchers, who are investigating its potential role in various diseases. Further studies are needed to fully understand its potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC105376234

The "LOC105376234 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376234 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290